Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to -$2.8 billion.

  • Fresenius Medical Care AG's Cash from Financing Activities fell 15330.44% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 billion, marking a year-over-year increase of 502.53%. This contributed to the annual value of -$2.8 billion for FY2024, which is 3906.58% down from last year.
  • As of FY2024, Fresenius Medical Care AG's Cash from Financing Activities stood at -$2.8 billion, which was down 3906.58% from -$2.0 billion recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Cash from Financing Activities ranged from a high of -$1.2 billion in FY2021 and a low of -$3.0 billion during FY2020
  • For the 5-year period, Fresenius Medical Care AG's Cash from Financing Activities averaged around -$2.1 billion, with its median value being -$2.0 billion (2023).
  • Per our database at Business Quant, Fresenius Medical Care AG's Cash from Financing Activities plummeted by 48204.05% in 2020 and then skyrocketed by 6147.36% in 2021.
  • Fresenius Medical Care AG's Cash from Financing Activities (Annual) stood at -$3.0 billion in 2020, then skyrocketed by 61.47% to -$1.2 billion in 2021, then plummeted by 45.46% to -$1.7 billion in 2022, then fell by 17.31% to -$2.0 billion in 2023, then crashed by 39.07% to -$2.8 billion in 2024.
  • Its Cash from Financing Activities was -$2.8 billion in FY2024, compared to -$2.0 billion in FY2023 and -$1.7 billion in FY2022.